Genetron Health is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, continuous disease monitoring and care, as wells as biopharma development services. Genetron Health offers customized services and products. The ultimate goal is to defeat cancer.
01
Our team of scientists has extensive experience in cancer genomics research, clinical and translational research. Our scientists have published more than one hundred papers in leading international academic journals. Our research fields include cancers of the lung, digestive tract, thyroid and the central nervous system. Genetron Health has established long-term partnerships with Duke University and Johns Hopkins University. Genetron Health’s innovative One-Step Seq Method and Mutation Capsule have proven to bring significant benefits to the clinical management of cancer.
02
Genetron Health's product and service solutions span the fields of early cancer screening, diagnosis and monitoring, biopharma services. Our products are capable of detecting multiple tissue and liquid sample forms. The two forms of "LDT testing service + IVD instrument reagent" focused on clinical appeals, have reliable service and product quality assurance. We have also been involved in writing a number of industry standards, and we are committed to providing solutions for healthy and high-risk groups, patients, doctors, and pharmaceutical companies.
03
Genetron Health is rooted in China with a global reach. Its international operations focus on market expansion across developed economies in Europe and the U.S., as well as Belt and Road countries. Through tailored strategies, it advances the regulatory approval and market penetration of precision oncology diagnostic products. Leveraging deep synergies with partners including AstraZeneca, Roche Pharmaceuticals, and BeiGene, Genetron Health is expanding its global footprint—dedicated to delivering end-to-end oncology solutions for more people worldwide.
04
Adhering to the mission of “Defeat Cancer and Protect Life”, Genetron Health is committed to becoming an excellent corporate citizen and protecting public health. We do this by focusing on users and providing users with products and services throughout the full cancer cycle. We do this by focusing on our employees, paying attention to their growth, by emphasizing equality and inclusiveness, by providing career opportunities through R & D and management, and by helping employees to achieve their dreams and ideals. We do this by focusing on the public and promoting the social awareness of the significance of precision medicine to health through public welfare such as health science popularization and community service.
